QUANTUM X LABS INC. quarterly report, Q2 FY2013

Business context and reporting period

Zaxis International Inc. (the registrant named in the filing; the request metadata names Quantum X Labs Inc.) filed this unaudited Form 10-Q for the quarter ended June 30, 2013. Zaxis reports that it has no current business operations and is pursuing a business combination. It describes itself as a shell company and says it has not selected a target business or industry.

Financial results and position

MetricQ2 2013 / June 30, 2013Comparable period / prior year-end
Revenue$0 for the quarter and six months$0 for the corresponding 2012 periods
Net loss$12,300 for Q2; $26,800 for six months$12,050 for Q2 2012; $26,100 for six months 2012
Operating expensesG&A $9,750 and interest $2,550 for Q2; G&A $21,700 and interest $5,100 for six monthsQ2 2012: G&A $9,500 and interest $2,550; six months 2012: G&A $21,000 and interest $5,100
Cash and total assets$0$0 at December 31, 2012
Total liabilities$254,179$227,379 at December 31, 2012
Stockholders’ deficit$254,179$227,379 at December 31, 2012
Operating cash flow$0 used for the six months$0 used for the six months ended June 30, 2012

With no revenue, a revenue margin is not meaningful. Current liabilities exceed current assets by $254,179. At June 30, liabilities included $142,229 due to related parties, $85,000 in convertible notes, and $26,950 of accrued interest. The notes bear 12% annual interest, mature December 31, 2013, and are convertible at $0.10 and $0.03 per share, respectively. Common shares outstanding were 1,695,126; the filing says management owns 82%.

Material changes versus comparable periods

Net loss increased $250 (about 2.1%) in Q2 and $700 (about 2.7%) for the first six months versus 2012. The six-month increase reflects higher G&A; interest expense was unchanged. Total liabilities rose $26,800 from year-end 2012, primarily alongside an increase in amounts due to related parties from $119,779 to $142,229, partly offset by trade accounts payable declining from $750 to $0. Cash remained zero.

Outlook, risks, and unusual items

Management intends to use its limited resources to seek a business combination but provides no specific guidance, timetable, or identified target. It says financing may be sought through restricted stock or debt, but there are no financing agreements and availability on acceptable terms is uncertain. A transaction could substantially dilute existing shareholders and could result in a change of control.

The filing states that losses, no revenue, and negative operational cash flows raise substantial doubt about the company’s ability to continue as a going concern; the financial statements include no adjustments for that uncertainty. The statements show zero operating cash use after noncash related-party services, expenses paid by a related party, and accrued liabilities. Management reported disclosure controls effective as of June 30, 2013 and no material change in internal control over financial reporting. No legal proceedings or unregistered equity sales were reported.

Important facts for investors to verify

  • Confirm the issuer’s identity: the supplied filing is for Zaxis International Inc., not Quantum X Labs Inc.
  • Verify the company’s shell status, lack of operations, and absence of an identified business-combination target.
  • Review related-party balances, services and advances, and the terms and December 31, 2013 maturity of the $85,000 convertible notes.
  • Assess the going-concern warning, zero cash and assets, financing uncertainty, and potential dilution or change of control from a future transaction.
  • Confirm management’s reported 82% ownership and current share count before relying on the filing’s control and dilution disclosures.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.